Pdpk1Gt(OST82857)Lex/Pdpk1Gt(OST82857)Lex
involves: 129S5/SvEvBrd * C57BL/6J
|
prenatal lethality, complete penetrance |
J:103485
|
Pdpk1tm1.1Daca/Pdpk1tm1.1Daca
involves: 129P2/OlaHsd * BALB/c
|
embryonic lethality during organogenesis, complete penetrance |
J:165626
|
Pdpk1tm1.1Mlw/Pdpk1tm1.1Mlw
involves: BALB/c
|
no abnormal phenotype detected |
J:85894
|
Pdpk1tm1.1Mlw/Pdpk1tm1.1Mlw Tg(Ckmm-cre)5Khn/?
involves: BALB/c
|
abnormal cardiovascular system morphology |
J:85498
|
abnormal cardiovascular system physiology |
J:85498
|
abnormal heart morphology |
J:85498
|
abnormal heart right ventricle morphology |
J:85498
|
abnormal heart ventricle morphology |
J:85498
|
abnormal myocardial fiber morphology |
J:85498
|
abnormal Z line morphology |
J:85498
|
decreased body weight |
J:85498
|
decreased cardiac muscle contractility |
J:85498
|
dilated cardiomyopathy |
J:85498
|
heart right ventricle hypertrophy |
J:85498
|
increased heart atrium size |
J:85498
|
myocardium hypoplasia |
J:85498
|
premature death |
J:85498
|
small heart |
J:85498
|
thin ventricular wall |
J:85498
|
Pdpk1tm1.2Mlw/Pdpk1tm1.2Mlw
involves: BALB/c
|
abnormal allantois morphology |
J:85894
|
abnormal cephalic neural fold morphology |
J:85894
|
abnormal embryonic tissue morphology |
J:85894
|
abnormal endoderm development |
J:85894
|
abnormal head development |
J:85894
|
abnormal neural crest cell physiology |
J:85894
|
abnormal presomitic mesoderm morphology |
J:85894
|
abnormal rostral-caudal body axis extension |
J:85894
|
absent dorsal root ganglion |
J:85894
|
absent forebrain |
J:85894
|
absent heart |
J:85894
|
absent heart tube |
J:85894
|
absent pharyngeal arches |
J:85894
|
absent somites |
J:85894
|
anophthalmia |
J:85894
|
decreased embryo size |
J:85894
|
embryonic lethality during organogenesis, complete penetrance |
J:85894
|
incomplete embryo turning |
J:85894
|
small allantois |
J:85894
|
Pdpk1tm1Dral/Pdpk1tm1Dral
B6.129P2-Pdpk1tm1Dral
|
abnormal kidney size |
J:136089
|
decreased adrenal gland zona fasciculata size |
J:136089
|
decreased body weight |
J:136089
|
decreased brain size |
J:136089
|
impaired glucose tolerance |
J:136089
|
increased circulating insulin level |
J:136089
|
insulin resistance |
J:136089
|
pancreatic islet hyperplasia |
J:136089
|
pancreatic islet hypoplasia |
J:136089
|
small pancreas |
J:136089
|
small spleen |
J:136089
|
small testis |
J:136089
|
Pdpk1tm1Ejm/Pdpk1tm1Ejm
involves: 129P2/OlaHsd * BALB/c
|
abnormal brain development |
J:90081
|
abnormal embryo development |
J:90081
|
abnormal extraembryonic tissue morphology |
J:90081
|
abnormal first pharyngeal arch morphology |
J:90081
|
abnormal forebrain morphology |
J:90081
|
abnormal placenta development |
J:90081
|
abnormal vasculogenesis |
J:90081
|
absent dorsal root ganglion |
J:90081
|
decreased embryo size |
J:90081
|
decreased forebrain size |
J:90081
|
embryonic lethality during organogenesis, complete penetrance |
J:90081
|
Pdpk1tm1Jcbr/Pdpk1tm1Jcbr Tg(Pomc1-cre)16Lowl/0
involves: C57BL/6 * FVB/N
|
abnormal circulating leptin level |
J:134336
|
abnormal glucose homeostasis |
J:134336
|
abnormal melanotroph morphology |
J:134336
|
decreased circulating corticosterone level |
J:134336
|
decreased circulating glucose level |
J:134336
|
decreased corticotroph cell number |
J:134336
|
decreased gonadal fat pad weight |
J:134336
|
decreased insulin secretion |
J:134336
|
improved glucose tolerance |
J:134336
|
increased body weight |
J:134336
|
increased circulating glucose level |
J:134336
|
increased insulin sensitivity |
J:134336
|
polyphagia |
J:134336
|
Pdpk1tm1Maka/Pdpk1tm1Maka Tg(Alb1-cre)1Dlr/0
involves: 129S4/SvJae * FVB/N
|
abnormal glucose homeostasis |
J:109359
|
impaired glucose tolerance |
J:109359
|
increased circulating glucose level |
J:109359
|
increased circulating insulin level |
J:109359
|
Pdpk1tm1Maka/Pdpk1tm1Maka Tg(CAG-cat,-lacZ)11Miya/0 Tg(Pomc1-cre)16Lowl/0
involves: 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N
|
abnormal homeostasis |
J:162892
|
abnormal neuron physiology |
J:162892
|
abnormal pituitary intermediate lobe morphology |
J:162892
|
decreased circulating corticosterone level |
J:162892
|
hypoglycemia |
J:162892
|
increased corticotroph apoptosis |
J:162892
|
increased food intake |
J:162892
|
increased insulin sensitivity |
J:162892
|
increased melanotroph apoptosis |
J:162892
|
increased pituitary gland apoptosis |
J:162892
|
increased total body fat amount |
J:162892
|
Pdpk1tm1Maka/Pdpk1tm1Maka Tg(Ins2-cre)23Herr/0
involves: 129S4/SvJae * C57BL/6J * CBA/J
|
abnormal pancreas physiology |
J:109010
|
abnormal pancreatic beta cell morphology |
J:109010
|
decreased body weight |
J:109010
|
decreased circulating insulin level |
J:109010
|
hyperglycemia |
J:109010
|
increased circulating glucose level |
J:109010
|
premature death |
J:109010
|
small pancreatic islets |
J:109010
|
Pdpk1tm1Maka/Pdpk1tm1Maka Tg(Zp3-cre)93Knw/0
involves: 129S4/SvJae * C57BL/6J
|
female infertility |
J:165798
|
maternal effect |
J:165798
|
Pdpk1tm1Mlw/Pdpk1tm1.1Daca Tg(Cd4-cre)1Cwi/0
involves: 129P2/OlaHsd * BALB/c * C57BL/6 * DBA/2
|
abnormal CD8-positive, alpha beta T cell morphology |
J:165626
|
decreased NK T cell number |
J:165626
|
decreased T cell number |
J:165626
|
Pdpk1tm1Mlw/Pdpk1tm1.2Mlw
involves: BALB/c
|
decreased body size |
J:85894
|
prenatal lethality, incomplete penetrance |
J:85894
|
Pdpk1tm1Mlw/Pdpk1tm1Mlw
involves: BALB/c
|
decreased birth body size |
J:85894
|
decreased body size |
J:85894
|
decreased body weight |
J:85894
|
prenatal lethality, incomplete penetrance |
J:85894
|
Pdpk1tm1Mlw/Pdpk1tm1Mlw Tg(Cd4-cre)1Cwi/0
involves: C57BL/6 * DBA/2
|
abnormal CD8-positive, alpha beta T cell morphology |
J:165626
|
abnormal NK T cell morphology |
J:165626
|
abnormal T cell differentiation |
J:165626
|
absent NK T cells |
J:165626
|
decreased NK T cell number |
J:165626
|
decreased T cell number |
J:165626
|
decreased T cell proliferation |
J:165626
|
normal
immune system phenotype |
J:165626
|
Pdpk1tm2Ejm/Pdpk1+
involves: 129P2/OlaHsd * BALB/c
|
prenatal lethality, incomplete penetrance |
J:90081
|
Pdpk1tm2Ejm/Pdpk1tm2Ejm
involves: 129P2/OlaHsd * BALB/c
|
abnormal brain development |
J:90081
|
abnormal developmental patterning |
J:90081
|
normal
cardiovascular system phenotype |
J:90081
|
decreased forebrain size |
J:90081
|
normal
embryo phenotype |
J:90081
|
embryonic growth retardation |
J:90081
|
embryonic lethality during organogenesis, complete penetrance |
J:90081
|
normal
nervous system phenotype |
J:90081
|
Gt(ROSA)26Sor/Gt(ROSA)26Sor+
Not Specified
|
abnormal glucose homeostasis |
J:170965
|
hyperglycemia |
J:170965
|
increased circulating insulin level |
J:170965
|